Advances in medical, biomedical, and health services research have reduced the level of uncertainty in clinical practice. Clinical practice guidelines (CPGs) complement this progress by establishing standards of care backed by strong scientific evidence. CPGs are statements that include recommendations intended to optimize patient care. These statements are informed by a systematic review of evidence and an assessment of the benefits and costs of alternative care options. Clinical Practice Guidelines We Can Trust examines the current state of CPGs and how they can be improved to enhance health care quality and patient outcomes. CPGs are now ubiquitous in health care systems. The Guidelines International Network (GIN) database currently lists more than 3,700 guidelines from 39 countries. Developing guidelines presents a number of challenges, including lack of transparent methodological practices, difficulty reconciling conflicting guidelines, and conflicts of interest. Clinical Practice Guidelines We Can Trust explores questions surrounding the quality of CPG development processes and the establishment of standards. It proposes eight standards for developing trustworthy CPGs emphasizing transparency; management of conflict of interest; systematic review - guideline development intersection; establishing evidence foundations for and rating strength of guideline recommendations; articulation of recommendations; external review; and updating. Clinical Practice Guidelines We Can Trust shows how CPGs can enhance clinician and patient decision making by translating complex scientific research findings into recommendations for clinical practice that are relevant to the individual patient encounter, instead of implementing a one-size-fits-all approach to patient care. This book contains information directly related to the work of the Agency for Healthcare Research and Quality, as well as various congressional staff and policy makers. It is a vital resource for medical specialty societies, disease advocacy groups, health professionals, private and international organizations that develop or use CPGs, consumers and clinicians.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Advances in medical, biomedical, and health services research have reduced the level of uncertainty in clinical practice. Clinical practice guidelines (CPGs) complement this progress by establishing standards of care backed by strong scientific evidence. CPGs are statements that include recommendations intended to optimize patient care. These statements are informed by a systematic review of evidence and an assessment of the benefits and costs of alternative care options. Clinical Practice Guidelines We Can Trust examines the current state of CPGs and how they can be improved to enhance health care quality and patient outcomes. CPGs are now ubiquitous in health care systems. The Guidelines International Network (GIN) database currently lists more than 3,700 guidelines from 39 countries. Developing guidelines presents a number of challenges, including lack of transparent methodological practices, difficulty reconciling conflicting guidelines, and conflicts of interest. Clinical Practice Guidelines We Can Trust explores questions surrounding the quality of CPG development processes and the establishment of standards. It proposes eight standards for developing trustworthy CPGs emphasizing transparency; management of conflict of interest; systematic review - guideline development intersection; establishing evidence foundations for and rating strength of guideline recommendations; articulation of recommendations; external review; and updating. Clinical Practice Guidelines We Can Trust shows how CPGs can enhance clinician and patient decision making by translating complex scientific research findings into recommendations for clinical practice that are relevant to the individual patient encounter, instead of implementing a one-size-fits-all approach to patient care. This book contains information directly related to the work of the Agency for Healthcare Research and Quality, as well as various congressional staff and policy makers. It is a vital resource for medical specialty societies, disease advocacy groups, health professionals, private and international organizations that develop or use CPGs, consumers and clinicians.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : 2nd Life Books, Burlington, NJ, Etats-Unis
Etat : good. Used book in good condition. May have some wear to binding, spine, cover, and pages. Some light highlighting markings writing may be present. May have some stickers and or sticker residue present. May be Ex-lib. copy. May NOT include discs, or access code or other supplemental material. We ship Monday-Saturday and respond to inquiries within 24 hours. N° de réf. du vendeur BXM.A64P
Quantité disponible : 1 disponible(s)
Vendeur : WeBuyBooks, Rossendale, LANCS, Royaume-Uni
Etat : Good. Most items will be dispatched the same or the next working day. A copy that has been read but remains in clean condition. All of the pages are intact and the cover is intact and the spine may show signs of wear. The book may have minor markings which are not specifically mentioned. N° de réf. du vendeur wbs5346071579
Quantité disponible : 1 disponible(s)
Vendeur : Toscana Books, AUSTIN, TX, Etats-Unis
Paperback. Etat : new. Excellent Condition.Excels in customer satisfaction, prompt replies, and quality checks. N° de réf. du vendeur Scanned0309164222
Quantité disponible : 1 disponible(s)
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Paperback. Etat : Brand New. 1st edition. 266 pages. 9.25x6.25x0.75 inches. In Stock. N° de réf. du vendeur 0309164222
Quantité disponible : 1 disponible(s)